![Donald DeGolyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald DeGolyer
Directeur/Membre du Conseil chez
EMERGENT BIOSOLUTIONS INC.
Fortune : 1 M $ au 31/05/2026
Profil
Mr. Donald W.
DeGolyer is an Independent Director at Emergent BioSolutions, Inc., a Founder at Strong Women Foundation, an Independent Director at Tyme, Inc., a Secretary & Director at Vertice Pharma UK Holdings Ltd. and a Secretary & Director at Vertice Pharma UK Intermediate Ltd. He is on the Board of Directors at Emergent BioSolutions, Inc., Xevant, Inc., Tyme, Inc., Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. and Vertice Pharma UK Intermediate Ltd. Mr. DeGolyer was previously employed as an Independent Director by Tyme Technologies, Inc., an Independent Director by HLS Therapeutics, Inc., a Chief Operating Officer by Endo Pharmaceuticals, Inc., a Chief Operating Officer by Endo International Plc, a President & Chief Executive Officer by Sandoz, Inc., a Vice Chairman by Association for Accessible Medicines, an Independent Director by HLS Therapeutics, Inc. /Old/, a Principal by Johnson & Johnson, a SVP-Managed Markets & Established Medicines by Novartis Pharmaceuticals Corp., a President-Global Therapeutics by Oxford GlycoSciences Plc, a Chief Operating Officer & Executive Vice President by ParkStone Medical Info Systems, and a Vice President-Marketing & Sales by Pfizer Inc. He also served on the board at Vertice Pharma LLC and Make-A-Wish Foundation of New Jersey.
He received his undergraduate degree from the University of Rochester and an MBA from Fairleigh Dickinson University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2026 | 129 721 ( 0,25 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Donald DeGolyer
| Sociétés | Poste | Début |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Directeur/Membre du Conseil | 28/09/2023 |
Xevant, Inc.
 Xevant, Inc. Packaged SoftwareTechnology Services Operates as a automated data analytics and reporting platform for pharmacy benefit organizations | Directeur/Membre du Conseil | 03/07/2023 |
Vertice Pharma UK Holdings Ltd.
 Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 21/10/2015 |
Vertice Pharma UK Intermediate Ltd.
 Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 21/10/2015 |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Provides research and development services focused on developing drug candidates for the treatment of cancer | Directeur/Membre du Conseil | 31/05/2018 |
Vertice Pharma UK Parent Ltd.
 Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Donald DeGolyer
| Sociétés | Poste | Fin |
|---|---|---|
| HLS THERAPEUTICS INC. | Directeur/Membre du Conseil | 16/06/2023 |
| TYME TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 16/09/2022 |
Vertice Pharma LLC
 Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Fondateur | 01/01/2022 |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Donald DeGolyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services Operate as a pharmaceutical association | Commercial Services |
ParkStone Medical Info Systems | |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Provides research and development services focused on developing drug candidates for the treatment of cancer | Health Technology |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
Vertice Pharma LLC
Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded & generic prescription medicines | Health Technology |
Vertice Pharma UK Parent Ltd.
Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Make-A-Wish Foundation of New Jersey
 Make-A-Wish Foundation of New Jersey The Make-A-Wish Foundation of New Jersey is a non-profit organization based in Monroe Township, NJ. | |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vertice Pharma UK Holdings Ltd.
Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Vertice Pharma UK Intermediate Ltd.
Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Xevant, Inc.
Xevant, Inc. Packaged SoftwareTechnology Services Operates as a automated data analytics and reporting platform for pharmacy benefit organizations | Technology Services |
Choisissez Zonebourse 
